Evidence from RCTs has shown that the benefits of each agent are maintained regardless of concomitant use [118,119], without a significant increase in the risk of hypoglycemia or AKI [120,121]
However, redness may occur in those with sensitive skin, as a result of opening the intravenous line
The BALP serum level in the osteoporotic group showed a significant increase compared to the control group by 2.85-fold
Ushakumari et al 183 have expressed reservations regarding The American Society of Anesthesiologists guidelines, highlighting the absence of evidence that discontinuing GLP-1RAs therapy for one day or one week reliably reduces the risk of gastroparesis
The goal is comprehensive metabolic health, not just a smaller body
It is also why its not a bad thing that retatrutide is less potent than glucagon